Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy
-
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
-
Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health
-
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market
-
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
-
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
-
Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
-
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset
-
Conduit Pharmaceuticals Announces Leadership Changes
-
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects